Sponsor

Inmune Bio, Inc.

Clinical research sponsor

Published trials5
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

5 shown
Study of INKmune in Patients With mCRPC (CaRe Prostate)NCT06056791 · lead sponsor · 2023-11-30
COMPLETED
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of InflammationNCT05321498 · lead sponsor · 2023-06-01
WITHDRAWN
An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseNCT05522387 · lead sponsor · 2023-02-21
TERMINATED
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of InflammationNCT05318976 · lead sponsor · 2022-02-28
COMPLETED
A Biomarker-directed Study of XPro1595 in Patients With Alzheimer'sNCT03943264 · lead sponsor · 2019-11-20
COMPLETED

Sponsor roles

lead sponsor5

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.